Abstract:Atrial fibrillation (AF) is the most common type of cardiac arrhythmia, occurring in 1% to 2% of the general population. The prevalence of AF increases with age, ranging from <1% in young adults to nearly 10% of those aged >80 years [ [1] Fuster V. Rydén L.E. Cannom D.S. et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 123: e269-e367 Crossref PubMed Scopus (730) Google Scholar ]. AF confers a 5-fold risk of stroke, and approximately 15% of all strokes are attributed to this tachycardia [ [2] Wolf P.A. Abbott R.D. Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22: 983-988 Crossref PubMed Scopus (5560) Google Scholar ]. AF is also an independent risk factor for death, with a risk ratio of 1.5 for men and 1.9 for women after adjustment for known risk factors [ [3] Benjamin E.J. Wolf P.A. D'Agostino R.B. Silbershatz H. Kannel W.B. Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98: 946-952 Crossref PubMed Scopus (3703) Google Scholar ]. AF has traditionally been perceived as a complication of various cardiac and systemic disorders, including hypertension, coronary artery disease, valvular heart disease, and hyperthyroidism [ [1] Fuster V. Rydén L.E. Cannom D.S. et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 123: e269-e367 Crossref PubMed Scopus (730) Google Scholar ]. However, 30% to 45% of AF occurs in the absence of any traditional risk factors, a condition classified as lone AF [ [1] Fuster V. Rydén L.E. Cannom D.S. et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011; 123: e269-e367 Crossref PubMed Scopus (730) Google Scholar ], of which at least 15% presents with a positive family history, so termed familial AF [ [4] Darbar D. Herron K.J. Ballew J.D. et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003; 41: 2185-2192 Abstract Full Text Full Text PDF PubMed Scopus (285) Google Scholar ]. There is accumulating evidence supporting that genetic factors play important roles in the pathogenesis of AF and multiple genes responsible for AF have been identified [ [5] Mahida S. Lubitz S.A. Rienstra M. Milan D.J. Ellinor P.T. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res. 2011; 89: 692-700 Crossref PubMed Scopus (76) Google Scholar ]. Nevertheless, AF is a genetically heterogeneous disorder and presently the genetic basis of AF remains largely unknown [ 4 Darbar D. Herron K.J. Ballew J.D. et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003; 41: 2185-2192 Abstract Full Text Full Text PDF PubMed Scopus (285) Google Scholar , 5 Mahida S. Lubitz S.A. Rienstra M. Milan D.J. Ellinor P.T. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res. 2011; 89: 692-700 Crossref PubMed Scopus (76) Google Scholar ].

Genetic basis of atrial fibrillation opyright

Genetic basis of atrial fibrillation.

The Genetics of Atrial Fibrillation: from the Bench to the Bedside.

Pathophysiology, molecular mechanisms, and genetics of atrial fibrillation

Atrial Fibrillation Genetic Considerations: The Basic Scientist'S Perspective

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Common variants for atrial fibrillation: results from genome-wide association studies

Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review.

Advances in Basic and Translational Research in Atrial Fibrillation.

Genetics and Pharmacogenetics of Atrial Fibrillation: A Mechanistic Perspective

Letter to the EditorPrevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation

A Network and Pathway Analysis of Genes Associated With Atrial Fibrillation

The Role of Transcription Factors in Atrial Fibrillation.

Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis

Large-scale Analyses of Common and Rare Variants Identify 12 New Loci Associated with Atrial Fibrillation

Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis

Integrative analysis of transcriptome-wide association study data and mRNA expression profiles identified candidate genes and pathways associated with atrial fibrillation.

Atrial fibrillation: mechanism and clinical management

Genetic aspects associated with increased risk of developing atrial fibrillation

Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses